NCT00481676 Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria Status COMPLETED Phase PHASE2
NCT00481065 Immunogenicity, Safety and Tolerability of Prepandemic Influenza and Seasonal Influenza Vaccine in Adult Subjects Status COMPLETED Phase PHASE2
NCT00477334 Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients Status COMPLETED Phase PHASE4
NCT00477217 Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee Status WITHDRAWN Phase PHASE2
NCT00476034 Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) Status COMPLETED Phase PHASE3
NCT00475800 Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA) Status COMPLETED Phase PHASE3
NCT00473642 Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration Status COMPLETED Phase PHASE4
NCT00473005 Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast Status TERMINATED Phase PHASE1
NCT00470704 Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00470678 EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) Status COMPLETED Phase PHASE3
NCT00470223 Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00468936 Myfortic in Heart Transplant Patients With Gastrointestinal (GI) Symptoms Status UNKNOWN Phase PHASE3
NCT00468039 A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin Status COMPLETED Phase PHASE3
NCT00467402 Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder Status COMPLETED Phase PHASE3
NCT00466609 Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment Status COMPLETED Phase PHASE4
NCT00466102 Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases Status UNKNOWN Phase PHASE2
NCT00465985 Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome Status COMPLETED Phase PHASE3
NCT00464880 Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic Nephropathy Status COMPLETED Phase PHASE1/PHASE2
NCT00464776 Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy Status COMPLETED Phase PHASE1/PHASE2